Announcements from CardioSignal, BioIntellisense, Astellas, Twilio
Tero-Pekka Alastalo, MD, PhD is the President and Chief Medical Officer CardioSignal Inc. He is a health care entrepreneur, investor, advisor, and board member. He has 10+ years of clinical and translational research experience and is an Adjunct Professor of Pediatrics at the University of Helsinki. He specialized in Pediatric Cardiology and did his postdoctoral training at Stanford University. He was a co-founder of Blueprint Genetics, a genetic testing laboratory for human rare diseases, that was acquired by Quest Diagnostics in 2020. At Blueprint Genetics he had several executive roles from commercial to medical affairs. He left Blueprint Genetics to join CardioSignal in 2021. He is an expert in cardiovascular medicine, genomic medicine, and medical devices for cardiovascular diseases. 
Tero-Pekka Alastalo, MD, PhD is the President and Chief Medical Officer CardioSignal Inc. He is a health care entrepreneur, investor, advisor, and board member. He has 10+ years of clinical and translational research experience and is an Adjunct Professor of Pediatrics at the University of Helsinki. He specialized in Pediatric Cardiology and did his postdoctoral training at Stanford University. He was a co-founder of Blueprint Genetics, a genetic testing laboratory for human rare diseases, that was acquired by Quest Diagnostics in 2020. At Blueprint Genetics he had several executive roles from commercial to medical affairs. He left Blueprint Genetics to join CardioSignal in 2021. He is an expert in cardiovascular medicine, genomic medicine, and medical devices for cardiovascular diseases. 
Dr. Jin Lee is the Director of Digital Health at Astellas Pharma Inc. She focuses on new product development and commercialization globally. Dr. Lee formerly worked at the innovation centers and venture arms of Humana and Providence St. Joseph Health. She also co-founded and worked in multiple startups in the maternal/ child, education, and restaurant space. Based in Silicon Valley, Dr. Lee advises and invests in multiple digital health startups and accelerator programs. She also serves on multiple nonprofit boards, including the American Heart Association and the Healthcare Businesswomen’s Association.  Dr. Lee is a Presidential Leadership Scholar (selected by four American presidential centers) and has been a featured speaker at multiple events such as the TEDxPeacePlaza, Sirius XM radio, SXSW, American Academy of Pediatrics, and Aspen Institute Children's Forum. She received her Ph.D in Neuropsychology from the University of Oxford and BA in Biology and Neuroscience from the University of Pennsylvania.
Dr. Jin Lee is the Director of Digital Health at Astellas Pharma Inc. She focuses on new product development and commercialization globally. Dr. Lee formerly worked at the innovation centers and venture arms of Humana and Providence St. Joseph Health. She also co-founded and worked in multiple startups in the maternal/ child, education, and restaurant space. Based in Silicon Valley, Dr. Lee advises and invests in multiple digital health startups and accelerator programs. She also serves on multiple nonprofit boards, including the American Heart Association and the Healthcare Businesswomen’s Association.  Dr. Lee is a Presidential Leadership Scholar (selected by four American presidential centers) and has been a featured speaker at multiple events such as the TEDxPeacePlaza, Sirius XM radio, SXSW, American Academy of Pediatrics, and Aspen Institute Children's Forum. She received her Ph.D in Neuropsychology from the University of Oxford and BA in Biology and Neuroscience from the University of Pennsylvania.
James Mault, MD, FACS, is the Founder and Chief Executive Officer of BioIntelliSense, a Data-as-a-Service (DaaS) platform company designed for scalable remote patient monitoring and virtual care data services. Prior to becoming the Founder of BioIntelliSense, Dr. Mault served as Senior Vice President and Chief Medical Officer of Qualcomm Life for over five years, where his leadership responsibilities included Strategic Planning and Business Development, Mergers and Acquisitions, New Product Innovation, Clinical Program and Regulatory Oversight, Health Policy and Government Affairs, Global Spokesperson and Public Relations. Dr. Mault came to Qualcomm Life through its 2013 acquisition of HealthyCircles, a Care Coordination and Remote Patient Monitoring Platform Company founded and led by Dr. Mault in 2009. Prior to starting HealthyCircles, he was the Medical the Health Solutions Group at Microsoft. Dr. Mault has more than 35 years of experience in senior executive positions in the Health IT and Medical Device industry as well as clinical medicine. He has founded five Health IT and medical device companies, raising over $150 million in working capital and leading these companies to develop novel devices and software technologies, FDA approvals, and strategic partnerships with numerous Fortune 500 companies, culminating in M&A and IPO exit transactions. He is the named inventor of over 80 issued and pending Patents for a variety of novel health IT and medical device innovations. He has been board- certified in both General Surgery and Cardiothoracic Surgery, having specialized in heart and lung transplantation, thoracic oncology and critical care. He has conducted academic medical research under grant awards from the National Institutes of Health, American Cancer Society, and others. He is the author of more than 60 scientific articles, chapters and books in the published medical literature. Dr. Mault received his B.S. in Biology and Medical Degree from the University of Michigan and conducted his General Surgery and Cardiothoracic Surgery residency training at Duke University Medical Center. Dr. Mault provides global thought-leadership on the future of technology and healthcare delivery, serving on numerous Boards and leadership positions including the Board of Directors of Bose Corporation, member of the Board of Industry Leaders for the Consumer Technology Association’s (CTA) and Chairman Emeritus of the CTA Health & Fitness Technology Board. Dr. Mault also serves on the University of Michigan Medical School’s Admission Committee and is a member of the Board of Trustees for the Astronaut Scholarship Foundation.
James Mault, MD, FACS, is the Founder and Chief Executive Officer of BioIntelliSense, a Data-as-a-Service (DaaS) platform company designed for scalable remote patient monitoring and virtual care data services. Prior to becoming the Founder of BioIntelliSense, Dr. Mault served as Senior Vice President and Chief Medical Officer of Qualcomm Life for over five years, where his leadership responsibilities included Strategic Planning and Business Development, Mergers and Acquisitions, New Product Innovation, Clinical Program and Regulatory Oversight, Health Policy and Government Affairs, Global Spokesperson and Public Relations. Dr. Mault came to Qualcomm Life through its 2013 acquisition of HealthyCircles, a Care Coordination and Remote Patient Monitoring Platform Company founded and led by Dr. Mault in 2009. Prior to starting HealthyCircles, he was the Medical the Health Solutions Group at Microsoft. Dr. Mault has more than 35 years of experience in senior executive positions in the Health IT and Medical Device industry as well as clinical medicine. He has founded five Health IT and medical device companies, raising over $150 million in working capital and leading these companies to develop novel devices and software technologies, FDA approvals, and strategic partnerships with numerous Fortune 500 companies, culminating in M&A and IPO exit transactions. He is the named inventor of over 80 issued and pending Patents for a variety of novel health IT and medical device innovations. He has been board- certified in both General Surgery and Cardiothoracic Surgery, having specialized in heart and lung transplantation, thoracic oncology and critical care. He has conducted academic medical research under grant awards from the National Institutes of Health, American Cancer Society, and others. He is the author of more than 60 scientific articles, chapters and books in the published medical literature. Dr. Mault received his B.S. in Biology and Medical Degree from the University of Michigan and conducted his General Surgery and Cardiothoracic Surgery residency training at Duke University Medical Center. Dr. Mault provides global thought-leadership on the future of technology and healthcare delivery, serving on numerous Boards and leadership positions including the Board of Directors of Bose Corporation, member of the Board of Industry Leaders for the Consumer Technology Association’s (CTA) and Chairman Emeritus of the CTA Health & Fitness Technology Board. Dr. Mault also serves on the University of Michigan Medical School’s Admission Committee and is a member of the Board of Trustees for the Astronaut Scholarship Foundation.
Erik is the Global Lead of Healthcare at Twilio. His background includes the inpatient, outpatient, and vendor sides of the healthcare business - giving him a unique understanding of the complex issues facing the industry today. Erik has worked with organizations across the globe to improve patient engagement and experience, reducing costs and decreasing employee burnout through improved workflow efficiencies within the entire healthcare ecosystem. He is an industry thought leader and speaker at international healthcare conferences, discussing digital solutions in today’s changing healthcare landscape.
Erik is the Global Lead of Healthcare at Twilio. His background includes the inpatient, outpatient, and vendor sides of the healthcare business - giving him a unique understanding of the complex issues facing the industry today. Erik has worked with organizations across the globe to improve patient engagement and experience, reducing costs and decreasing employee burnout through improved workflow efficiencies within the entire healthcare ecosystem. He is an industry thought leader and speaker at international healthcare conferences, discussing digital solutions in today’s changing healthcare landscape.